Knowing the role of IL-36 in the obesity-associated low-grade inflammation and the importance of chronic inflammation in the physiopathology of cancer, we hypothesised that increased expression levels of IL36G in dysfunctional AT in obesity may favour CC development by increasing inflammation. The gene discussed is IL36G; the disease is obesity disorder.